company

MYCOTECH PHARMA AS

0283 OSLO

Return on Equity
−135,37 %
Current Ratio
3,05
Debt-to-Equity Ratio
3,77
Key figures (NOK)2022
Revenue1 196 000
Net Income−11 398 000
Total Assets41 954 000
Total Equity8 420 000
Income (NOK)2022
Revenue1 196 000
Expenditure11 058 000
Operating Profit−10 700 000
Financial Income24 000
Financial Costs723 000
Financial Balance−699 000
Earnings Before Tax−11 398 000
Tax0
Net Income−11 398 000
Balance (NOK)2022
Total Fixed Assets36 431 000
Total Current Assets5 523 000
Total Assets41 954 000
Total Retained Equity−1 838 000
Total Equity8 420 000
Total Long-Term Debt31 722 000
Total Current Debt1 812 000
Total Equity and Debt41 954 000
Cash flow (NOK)2022
Sales Income1 196 000
Other Income0
Revenue1 196 000
Cost of Goods Sold0
Salary Costs284 000
Depreciation4 342 000
Impairment0
Expenditure11 058 000
Operating Profit−10 700 000
Financial Income24 000
Financial Costs723 000
Financial Balance−699 000
Dividends0
Net Income−11 398 000
Balance details (NOK)2022
Goodwill19 000 000
Total Intangible Assets20 880 000
Real Eastate8 451 000
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets8 451 000
Total Fiancial Fixed Assets7 100 000
Total Fixed Assets36 431 000
Stock416 000
Total Investments0
Cash, Bank2 708 000
Total Current Assets5 523 000
Total Assets41 954 000
Total Equity8 420 000
Short-Term Group Debt63 000
Total Long-Term Debt31 722 000
Creditors1 517 000
Unpaid Taxes178 000
Dividends0
Other Current Debt54 000
Total Current Debt1 812 000
Total Equity and Debt41 954 000
Financial indicators2022
Return on Equity−135,37 %
Debt-to-Equity Ratio3,77
Operating Profit Margin−894,65 %
Current Ratio3,05
Quick Ratio3,96
Equity Ratio0,2
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English